carbamates has been researched along with Dermatitis Medicamentosa in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "B-rapidly accelerated fibrosarcoma (BRAF) inhibitor encorafenib alone and in combination with MEK inhibitor binimetinib improves survival in BRAF-mutated melanoma patients." | 7.91 | The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B-rapidly accelerated fibrosarcoma-mutated advanced melanoma. ( Barysch, M; Cheng, PF; Conrad, S; Dummer, R; Galliker, N; Goldinger, SM; Graf, NP; Koelblinger, P; Mangana, J, 2019) |
| "B-rapidly accelerated fibrosarcoma (BRAF) inhibitor encorafenib alone and in combination with MEK inhibitor binimetinib improves survival in BRAF-mutated melanoma patients." | 3.91 | The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B-rapidly accelerated fibrosarcoma-mutated advanced melanoma. ( Barysch, M; Cheng, PF; Conrad, S; Dummer, R; Galliker, N; Goldinger, SM; Graf, NP; Koelblinger, P; Mangana, J, 2019) |
| "Objective An open-label, three-period pharmacokinetic study was conducted to investigate the drug interaction potential between fosamprenavir (FPV) and tenofovir disoproxil fumarate (TDF)." | 2.75 | Steady-state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir-boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteers. ( Andrews, M; Condoluci, DV; Luber, AD; Olson, K; Pakes, GE; Pappa, KA; Peloquin, CA; Slowinski, PD, 2010) |
| "Ezogabine (retigabine) was recently approved as an add-on drug for the treatment of partial seizures in adults with epilepsy." | 1.40 | Blue-gray mucocutaneous discoloration: a new adverse effect of ezogabine. ( Bergman, R; Didkovsky, E; Feuerman, H; Garin Shkolnik, T; Hodak, E; Kaplan, I; Pavlovsky, L, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Navarro-Triviño, FJ | 1 |
| Muñoz-Medina, L | 1 |
| Navarro-Navarro, I | 1 |
| Ruiz-Villaverde, R | 1 |
| Graf, NP | 1 |
| Koelblinger, P | 1 |
| Galliker, N | 1 |
| Conrad, S | 1 |
| Barysch, M | 1 |
| Mangana, J | 1 |
| Dummer, R | 1 |
| Cheng, PF | 1 |
| Goldinger, SM | 1 |
| Garin Shkolnik, T | 1 |
| Feuerman, H | 1 |
| Didkovsky, E | 1 |
| Kaplan, I | 1 |
| Bergman, R | 1 |
| Pavlovsky, L | 1 |
| Hodak, E | 1 |
| Wang, Y | 1 |
| Liu, P | 1 |
| Luber, AD | 1 |
| Condoluci, DV | 1 |
| Slowinski, PD | 1 |
| Andrews, M | 1 |
| Olson, K | 1 |
| Peloquin, CA | 1 |
| Pappa, KA | 1 |
| Pakes, GE | 1 |
| Hagedorn, M | 1 |
1 review available for carbamates and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Cutaneous eruptions by new therapies against hepatitis C virus infection. Not as common as we presumed.
Topics: 2-Naphthylamine; Adrenal Cortex Hormones; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Dru | 2018 |
1 trial available for carbamates and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Steady-state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir-boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteers.
Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Carbamates; Cross-Over Studies; Drug Administrati | 2010 |
5 other studies available for carbamates and Dermatitis Medicamentosa
| Article | Year |
|---|---|
The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B-rapidly accelerated fibrosarcoma-mutated advanced melanoma.
Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carbamates; Drug Eru | 2019 |
Blue-gray mucocutaneous discoloration: a new adverse effect of ezogabine.
Topics: Adult; Anticonvulsants; Carbamates; Drug Eruptions; Female; Humans; Hypopigmentation; Mucous Membran | 2014 |
A case of erythema multiforme drug eruption associated with erythrodermic psoriasis induced by sofosbuvir and daclatasvir.
Topics: Carbamates; Drug Eruptions; Erythema Multiforme; Humans; Imidazoles; Male; Middle Aged; Psoriasis; P | 2017 |
Cutaneous drug reaction case reports: from the world literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Capecitabine; Carbamates; Ceftriaxone; Clonidine; Deoxyc | 2002 |
[Skin necrosis following bromocarbamide intoxication].
Topics: Adult; Bromides; Carbamates; Drug Eruptions; Humans; Hypnotics and Sedatives; Male; Microcirculation | 1974 |